It has been shown that the stimulatory effect of GLP-1 on insulin secretion is, to some extent, dependent on PKC, as evidenced by the ability of the PKC activator phorbol 12-myristate 13-acetate to mimic the effects of GLP-1 on electrical activity
Document your rationale (e.g., patient has obesity + BED, traditional BED treatments ineffective, GLP-1 may reduce binge frequency and aid weight loss) and get informed consent
Tissue renin-angiotensin system (Tras) induce intervertebral disc degeneration by activating oxidative stress and inflammatory reaction
Key Takeaways: GLP-1 (Glucagon-Like Peptide-1 agonist) drugs are prescription medications used to treat type 2 diabetes and obesity but carry serious side effects and must only be taken under the supervision of a qualified medical specialist
Free radical scavengers attenuated AdoMet effects on lipid peroxidation and GSH levels, supporting a role of ROS in these effects
patient education/training and device calibration